NCT06882265Recruiting
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy : a Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 18 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Assess quality of life of patients using prolonged oxygen therapy
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 18 Feb 2025
- Start date
- 10 Nov 2024
- Primary completion date
- 30 Jul 2025
- Lead sponsor
- University of Sao Paulo General Hospital
- Diseases
- COPD
- NCT number
- NCT06882265
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 10 Nov 2024 to the primary completion date, 30 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of other concomitant lung diseases;
- Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated.
- Patients who received a lung transplant during the study
Other
- Living outside the coverage area or moving out of state
Who the study is looking for
- Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines;
- Age over 18 years;
- Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks;
- Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT)
- Have a smartphone compatible with the monitoring device;
- Signing of the ICF to participate in the study.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo Hcfmusp Coordinator of this site? Confirm its status | São Paulo | Brazil | Recruiting |
Related publications
- Effect of Remote Vital Signs Monitoring in People Receiving Long-Term Oxygen Therapy: Protocol for a Randomized Controlled Trial.JMIR Res Protoc · 2026 · PMID 42628026
This page is information, not medical advice. Discuss any trial with your doctor.